JP2015501830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015501830A5 JP2015501830A5 JP2014546649A JP2014546649A JP2015501830A5 JP 2015501830 A5 JP2015501830 A5 JP 2015501830A5 JP 2014546649 A JP2014546649 A JP 2014546649A JP 2014546649 A JP2014546649 A JP 2014546649A JP 2015501830 A5 JP2015501830 A5 JP 2015501830A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody molecule
- seq
- amino acid
- thrombin
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1121513.4A GB201121513D0 (en) | 2011-12-14 | 2011-12-14 | Thrombin-binding antibody molecules and uses thereof |
| GB1121513.4 | 2011-12-14 | ||
| PCT/GB2012/053140 WO2013088164A1 (en) | 2011-12-14 | 2012-12-14 | Thrombin-binding antibody molecules and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017165700A Division JP6705785B2 (ja) | 2011-12-14 | 2017-08-30 | トロンビン結合性抗体分子及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015501830A JP2015501830A (ja) | 2015-01-19 |
| JP2015501830A5 true JP2015501830A5 (https=) | 2017-02-02 |
| JP6216954B2 JP6216954B2 (ja) | 2017-10-25 |
Family
ID=45560465
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014546649A Expired - Fee Related JP6216954B2 (ja) | 2011-12-14 | 2012-12-14 | トロンビン結合性抗体分子及びその使用 |
| JP2017165700A Expired - Fee Related JP6705785B2 (ja) | 2011-12-14 | 2017-08-30 | トロンビン結合性抗体分子及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017165700A Expired - Fee Related JP6705785B2 (ja) | 2011-12-14 | 2017-08-30 | トロンビン結合性抗体分子及びその使用 |
Country Status (34)
| Country | Link |
|---|---|
| US (5) | US9518129B2 (https=) |
| EP (2) | EP2791177B1 (https=) |
| JP (2) | JP6216954B2 (https=) |
| KR (1) | KR102114506B1 (https=) |
| CN (2) | CN107936119B (https=) |
| AU (2) | AU2012351858B2 (https=) |
| BR (1) | BR112014014605A2 (https=) |
| CA (1) | CA2856656C (https=) |
| CO (1) | CO7101192A2 (https=) |
| CY (1) | CY1119599T1 (https=) |
| DK (1) | DK2791177T3 (https=) |
| ES (1) | ES2642718T3 (https=) |
| GB (1) | GB201121513D0 (https=) |
| HK (1) | HK1246326A1 (https=) |
| HR (1) | HRP20171775T1 (https=) |
| HU (1) | HUE034793T2 (https=) |
| IL (1) | IL232797B (https=) |
| LT (1) | LT2791177T (https=) |
| ME (1) | ME02901B (https=) |
| MX (2) | MX376876B (https=) |
| MY (1) | MY170980A (https=) |
| NO (1) | NO2791177T3 (https=) |
| PE (2) | PE20141706A1 (https=) |
| PH (1) | PH12014501169A1 (https=) |
| PL (1) | PL2791177T3 (https=) |
| PT (1) | PT2791177T (https=) |
| RS (1) | RS56510B1 (https=) |
| RU (2) | RU2642276C2 (https=) |
| SG (1) | SG11201402560WA (https=) |
| SI (1) | SI2791177T1 (https=) |
| SM (1) | SMT201700580T1 (https=) |
| UA (1) | UA116531C2 (https=) |
| WO (1) | WO2013088164A1 (https=) |
| ZA (1) | ZA201403836B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9518128B2 (en) * | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| GB201310949D0 (en) * | 2013-06-19 | 2013-07-31 | Cambridge Entpr Ltd | Binding Motif |
| GB201310948D0 (en) * | 2013-06-19 | 2013-07-31 | Cambridge Entpr Ltd | Screening methods |
| CN107043423B (zh) * | 2016-02-05 | 2021-02-26 | 江苏恒瑞医药股份有限公司 | 凝血酶抗体、其抗原结合片段及医药用途 |
| CA3013254A1 (en) * | 2016-02-05 | 2017-08-10 | Jiangsu Hengrui Medicine Co., Ltd. | Thrombin antibody, antigen-binding fragment and pharmaceutical use thereof |
| WO2018081534A1 (en) * | 2016-10-28 | 2018-05-03 | President And Fellows Of Harvard College | Assay for exo-site binding molecules |
| WO2019030706A1 (en) | 2017-08-10 | 2019-02-14 | Janssen Pharmaceutica Nv | ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE IN ORTHOPEDIC SURGERY |
| WO2019035055A1 (en) | 2017-08-16 | 2019-02-21 | Janssen Pharmaceutica Nv | ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE WITH PLATELET ANTI-AGGREGATE AGENTS |
| WO2020003077A1 (en) * | 2018-06-25 | 2020-01-02 | Janssen Pharmaceutica Nv | Anti-thrombin antibody molecules for use in patients at risk for gastrointestinal (gi) bleeding |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68908175T2 (de) * | 1988-05-27 | 1994-03-03 | Centocor Inc | Gefriergetrocknete formulierung für antikörperprodukte. |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5196404B1 (en) | 1989-08-18 | 1996-09-10 | Biogen Inc | Inhibitors of thrombin |
| US5240913A (en) | 1989-08-18 | 1993-08-31 | Biogen, Inc. | Inhibitors of thrombin |
| CA2082643A1 (en) | 1990-05-10 | 1991-11-11 | Jan H. Nuijens | Inhibitors of factor xii activation and applications thereof |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5443827A (en) * | 1993-05-03 | 1995-08-22 | President And Fellows Of Harvard College | Fibrin-targeted inhibitors of thrombin |
| CA2180140A1 (en) * | 1993-12-27 | 1995-07-06 | Jeffrey I. Weitz | Methods and compositions for inhibiting thrombogenesis |
| GB9613718D0 (en) | 1996-06-29 | 1996-08-28 | Thrombosis Res Inst | Thrombin inhibitors |
| US5985833A (en) | 1996-09-17 | 1999-11-16 | Wisconsin Alumni Research Foundation | Thrombin inhibitor |
| WO2001000667A2 (en) | 1999-06-29 | 2001-01-04 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-thrombin peptide from anopheles albimanus salivary gland |
| CA2378473A1 (en) * | 1999-07-23 | 2001-02-01 | The Regents Of The University Of California | Modulation of platelet activation |
| KR20070116192A (ko) * | 2000-05-15 | 2007-12-06 | 스미스클라인 비참 코포레이션 | 항혈전제 |
| AU2001286900A1 (en) | 2000-08-31 | 2002-03-13 | Cor Therapeutics, Inc. | Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| CA2453202C (en) * | 2001-07-06 | 2012-10-16 | Oregon Health & Science University | Peptides which modulate blood coagulation and methods of use thereof |
| TWI338009B (en) * | 2001-10-29 | 2011-03-01 | Genentech Inc | Antibodies for inhibiting blood coagulation and methods of use thereof |
| MEP0208A (xx) | 2005-08-26 | 2010-02-10 | Archemix Corp | Aptameri koji vezuje trombin sa visokim afininitetom |
| US20100158890A1 (en) | 2006-03-15 | 2010-06-24 | Kenichi Tanaka | Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| GB0711779D0 (en) | 2007-06-18 | 2007-07-25 | Univ Singapore | Thrombin inhibitor |
| TR201820051T4 (tr) | 2008-06-19 | 2019-01-21 | Prothix Bv | Anti-faktör XI Antikorlarının Trombüs Oluşumunun Engellenmesi Veya Tedavisi İçin Kullanılması |
| WO2010033167A2 (en) * | 2008-09-18 | 2010-03-25 | Archemix Corp. | Anti-thrombin aptamer formulations and methods for use |
| IL230564B2 (en) | 2011-07-22 | 2023-09-01 | Csl Ltd | Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses. |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| US9518128B2 (en) * | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
-
2011
- 2011-12-14 GB GBGB1121513.4A patent/GB201121513D0/en not_active Ceased
-
2012
- 2012-12-14 ME MEP-2017-243A patent/ME02901B/me unknown
- 2012-12-14 MX MX2018000197A patent/MX376876B/es unknown
- 2012-12-14 NO NO12806641A patent/NO2791177T3/no unknown
- 2012-12-14 US US14/363,514 patent/US9518129B2/en not_active Expired - Fee Related
- 2012-12-14 CN CN201711384542.3A patent/CN107936119B/zh not_active Expired - Fee Related
- 2012-12-14 CN CN201280061294.8A patent/CN104053673B/zh not_active Expired - Fee Related
- 2012-12-14 SG SG11201402560WA patent/SG11201402560WA/en unknown
- 2012-12-14 RU RU2014124985A patent/RU2642276C2/ru active
- 2012-12-14 JP JP2014546649A patent/JP6216954B2/ja not_active Expired - Fee Related
- 2012-12-14 SM SM20170580T patent/SMT201700580T1/it unknown
- 2012-12-14 MX MX2014007170A patent/MX353281B/es active IP Right Grant
- 2012-12-14 SI SI201231145T patent/SI2791177T1/en unknown
- 2012-12-14 MY MYPI2014001764A patent/MY170980A/en unknown
- 2012-12-14 PE PE2014000953A patent/PE20141706A1/es active IP Right Grant
- 2012-12-14 PL PL12806641T patent/PL2791177T3/pl unknown
- 2012-12-14 BR BR112014014605A patent/BR112014014605A2/pt not_active Application Discontinuation
- 2012-12-14 HR HRP20171775TT patent/HRP20171775T1/hr unknown
- 2012-12-14 LT LTEP12806641.2T patent/LT2791177T/lt unknown
- 2012-12-14 ES ES12806641.2T patent/ES2642718T3/es active Active
- 2012-12-14 UA UAA201406892A patent/UA116531C2/uk unknown
- 2012-12-14 CA CA2856656A patent/CA2856656C/en active Active
- 2012-12-14 AU AU2012351858A patent/AU2012351858B2/en not_active Ceased
- 2012-12-14 KR KR1020147019168A patent/KR102114506B1/ko not_active Expired - Fee Related
- 2012-12-14 EP EP12806641.2A patent/EP2791177B1/en active Active
- 2012-12-14 PE PE2018002007A patent/PE20190171A1/es unknown
- 2012-12-14 HU HUE12806641A patent/HUE034793T2/en unknown
- 2012-12-14 DK DK12806641.2T patent/DK2791177T3/en active
- 2012-12-14 RS RS20171073A patent/RS56510B1/sr unknown
- 2012-12-14 WO PCT/GB2012/053140 patent/WO2013088164A1/en not_active Ceased
- 2012-12-14 RU RU2017144629A patent/RU2017144629A/ru unknown
- 2012-12-14 EP EP17177235.3A patent/EP3275903A1/en not_active Withdrawn
- 2012-12-14 PT PT128066412T patent/PT2791177T/pt unknown
-
2014
- 2014-05-26 IL IL232797A patent/IL232797B/en active IP Right Grant
- 2014-05-26 PH PH12014501169A patent/PH12014501169A1/en unknown
- 2014-05-26 ZA ZA2014/03836A patent/ZA201403836B/en unknown
- 2014-07-11 CO CO14150372A patent/CO7101192A2/es unknown
-
2016
- 2016-11-10 US US15/348,250 patent/US9988463B2/en active Active
-
2017
- 2017-08-30 JP JP2017165700A patent/JP6705785B2/ja not_active Expired - Fee Related
- 2017-11-14 CY CY20171101189T patent/CY1119599T1/el unknown
- 2017-12-01 AU AU2017268655A patent/AU2017268655B2/en not_active Ceased
-
2018
- 2018-05-08 HK HK18105913.3A patent/HK1246326A1/en unknown
- 2018-05-10 US US15/976,512 patent/US10287363B2/en not_active Expired - Fee Related
-
2019
- 2019-03-25 US US16/363,396 patent/US20190276558A1/en not_active Abandoned
-
2021
- 2021-06-10 US US17/344,577 patent/US20210371543A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015501830A5 (https=) | ||
| AU2018250301B2 (en) | Anti-ICOS agonist antibodies and uses thereof | |
| JP2025134874A (ja) | ブラジキニンｂ１受容体リガンドに対する抗体 | |
| RU2486198C2 (ru) | Антиген, ассоциированный с ревматоидным артритом | |
| JP6696899B2 (ja) | プラスミノーゲン活性化因子阻害剤−１（ｐａｉ−１）に対する抗体及びその使用 | |
| JP2021129594A (ja) | 中東呼吸器症候群−コロナウイルススパイクタンパク質に対するヒト抗体 | |
| JP2018521691A5 (https=) | ||
| HRP20210393T1 (hr) | Anti-tfr antitijela i njihova uporaba u liječenju proliferativnih i upalnih poremećaja | |
| KR101773505B1 (ko) | 인간 ｉｌ-１３에 대한 결합 특이성을 갖는 항체 분자 | |
| CN110167960B (zh) | 针对金黄色葡萄球菌溶血素a毒素的人类抗体 | |
| TWI592426B (zh) | 胞漿素原活化素抑制劑－１（ｐａｉ－１）之抗體及其用途 | |
| RU2017144629A (ru) | Тромбин-связывающие молекулы антител и их применение | |
| KR20210002499A (ko) | 항-cd38 항체의 피하 투여 | |
| RU2011152816A (ru) | ПРИМЕНЕНИЕ АНТИТЕЛА ПРОТИВ Tau pS422 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ГОЛОВНОГО МОЗГА | |
| TW201333038A (zh) | ＰＤＧＦ受體β結合多肽 | |
| CA2904995A1 (en) | Human antibodies to respiratory syncytial virus f protein and methods of use thereof | |
| CN107405399A (zh) | 针对血浆激肽释放酶和因子xii的双特异性抗体 | |
| RU2016122340A (ru) | Il-17a-связующий агент и способы его применения | |
| JP2018529635A5 (https=) | ||
| JP2015515492A5 (https=) | ||
| WO2018183366A1 (en) | Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy | |
| EP2822966B1 (en) | Treatment of mucositis with immunoglobulin a | |
| JP2013538813A5 (https=) | ||
| JP2024511853A5 (https=) | ||
| CN111278459A (zh) | 组合疗法 |